SCHEMBL4897479

SCHEMBL4897479

COC(=O)c1cc(S(=O)(=O)NCCc2nc3cc(-c4ccccc4)ccc3o2)ccc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.43
PTPN2 P17706 3/20 0.42
PTPN1 P18031 3/20 0.42
PTPN5 P54829 3/20 0.42
LIPG Q9Y5X9 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CETP P11597 1/20 0.40
TP53 P04637 2/20 0.40
GAA P10253 2/20 0.40
RAB9A P51151 2/20 0.40
NPC1 O15118 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HSPD1 P10809 2/20 0.40
HSPE1 P61604 2/20 0.40
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
FBP1 P09467 1/20 0.39
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904425 0.93 LMNA (0.52) LMNAPTPN2PTPN1PTPN5LIPG
SCHEMBL4906063 0.89 LMNA (0.45) LMNAALDH1A1TP53GAARAB9A
SCHEMBL4906354 0.88 KDR (0.42) LMNAPTPN2PTPN1PTPN5ALDH1A1
SCHEMBL4902731 0.86 MEN1 (0.44) LMNATP53MAPTMEN1KMT2A
SCHEMBL4895325 0.85 NR1I2 (0.39) LMNAPTPN2PTPN1PTPN5ALDH1A1
SCHEMBL4905165 0.83 PTPN5 (0.52) LMNAPTPN2PTPN1PTPN5ALDH1A1
SCHEMBL4897492 0.83 KDR (0.45) LMNAPTPN2PTPN1PTPN5ALDH1A1
SCHEMBL4895604 0.82 NPC1 (0.40) LMNAPTPN2PTPN1PTPN5ALDH1A1
SCHEMBL4899808 0.82 LMNA (0.56) LMNAALDH1A1TP53RAB9ANPC1
SCHEMBL4903825 0.81 LMNA (0.50) LMNAALDH1A1TP53L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD LMNA 317/4885PTPN2 2168/4885PTPN1 1702/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885PTPN2 2720/4885PTPN1 2340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.